2011.12.22 Weekly Broadcast Email
There were no updates made to the CCCWFU CCOP Research Base website for the week of December 19, 2011.
Due to the holidays, the Protocol Information Office will be closed Monday, December 26 through Monday, January 2. The Data Management Center and Clinic staff will be available Tuesday, December 27 through Friday, December 30.
91105(Phase III Double Blind, Placebo Controlled Study of Donepezil in Irradiated Brain Tumor Patients)
Announcement from study PI:
91105 is nearing completion of enrollment with 197 of 200 participants enrolled. We still need 3 additional enrollments to reach our goal, however. Please try to help us reach our goal by December. This study will be closed to enrollment at the end of this month. Also, please send in the MRIs as soon as possible so we can process your reimbursement. Thanks!!
Steve Rapp, PhD, PI
97609(Impact of Genomics and Exposures on Disparities in Breast Cancer Radiosensitivity)
Announcement from Lab Staff:
Due to the upcoming holiday, samples will be accepted by the lab Tuesday (12/27) through Wednesday (12/28.)
98110 (ArginMax for Prostate Cancer Survivors Treated with Radiotherapy)
Announcement from study PI:
As a reminder, our dose finding study of ArginMax for prostate cancer survivors treated with radiotherapy remains open for accrual. To date, we have accrued 70 + patients of a planned 140 averaging nearly 6 patients per month. We appreciate the robust accrual to date and overall support of this study. During the past month, we have noticed a slight dip in accrual. We encourage all sites to continue either their excellent accrual or consider opening this study. With your continued robust support, we are likely to finish this study in about 1 more year. If there are questions regarding accrual please do not hesitate to contact me or the study team.
James J. Urbanic, M.D.
Wake Forest Baptist Health
Department of Radiation Oncology
Research Base Protocol Information Office
2000 West First Street, Suite 401
Winston-Salem, NC 27104
**Please note my email address change email@example.com.
CONFIDENTIAL AND PRIVILEGED: The information contained in this electronic message may be privileged and confidential information intended for the sole use of the addressee and any personnel receiving a copy. If the reader of this electronic message is not the intended recipient, or the employee or agent responsible for delivering it to the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this electronic message in error, please notify me immediately by responding to this message.
WITHHOLD FROM PUBLIC DISCLOSURE UNDER N.C.G.S. 104E-9(a)(4)